Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of Immunoglobulin light chain (AL) amyloidosis: A pooled analysis.

Sanchorawala V, Doros G, Shelton AC.

Am J Hematol. 2019 Apr 24. doi: 10.1002/ajh.25497. [Epub ahead of print] No abstract available.

PMID:
31020691
2.

Early Detection of Multiorgan Light Chain (AL) Amyloidosis by Whole Body 18F-florbetapir PET/CT.

Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Falk RH, Hyun H, Dorbala S.

J Nucl Med. 2019 Apr 6. pii: jnumed.118.221770. doi: 10.2967/jnumed.118.221770. [Epub ahead of print]

PMID:
30954943
3.

Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details.

Sanchorawala V.

Blood Adv. 2019 Jan 22;3(2):216-218. doi: 10.1182/bloodadvances.2018021261. No abstract available.

4.

High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators.

Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S.

Bone Marrow Transplant. 2019 Jan 21. doi: 10.1038/s41409-019-0440-5. [Epub ahead of print]

PMID:
30664726
5.

Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis.

Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V.

Biol Blood Marrow Transplant. 2019 May;25(5):e169-e173. doi: 10.1016/j.bbmt.2019.01.007. Epub 2019 Jan 11.

PMID:
30639823
6.

Long-term outcome of kidney transplantation in AL amyloidosis.

Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A.

Kidney Int. 2019 Feb;95(2):405-411. doi: 10.1016/j.kint.2018.09.021. Epub 2018 Dec 21.

PMID:
30580886
7.

Bortezomib ocular toxicities: Outcomes with ketotifen.

Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S.

Am J Hematol. 2019 Mar;94(3):E80-E82. doi: 10.1002/ajh.25382. Epub 2019 Jan 3. No abstract available.

PMID:
30575098
8.

Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis.

McCausland KL, Quock TP, Rizio AA, Bayliss MS, White MK, Guthrie SD, Sanchorawala V.

Br J Haematol. 2018 Nov 22. doi: 10.1111/bjh.15693. [Epub ahead of print] No abstract available.

PMID:
30467849
9.

Systemic immunoglobulin light chain amyloidosis.

Merlini G, Dispenzieri A, Sanchorawala V, Schönland SO, Palladini G, Hawkins PN, Gertz MA.

Nat Rev Dis Primers. 2018 Oct 25;4(1):38. doi: 10.1038/s41572-018-0034-3. Review.

PMID:
30361521
10.

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis.

Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V.

Blood. 2019 Jan 17;133(3):215-223. doi: 10.1182/blood-2018-06-858951. Epub 2018 Oct 17.

PMID:
30333122
11.

A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics.

Giadone RM, Rosarda JD, Akepati PR, Thomas AC, Boldbaatar B, James MF, Wilson AA, Sanchorawala V, Connors LH, Berk JL, Wiseman RL, Murphy GJ.

Amyloid. 2018 Sep;25(3):148-155. doi: 10.1080/13506129.2018.1489228. Epub 2018 Jul 21.

PMID:
30032658
12.

Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis.

Nguyen VP, Rosenberg A, Mendelson LM, Comenzo RL, Varga C, Sanchorawala V.

Amyloid. 2018 Sep;25(3):156-159. doi: 10.1080/13506129.2018.1490261. Epub 2018 Jul 21.

PMID:
30032640
13.

Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis.

Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1823-1827. doi: 10.1016/j.bbmt.2018.06.018. Epub 2018 Jun 20.

PMID:
29933072
14.

Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation.

Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V.

Blood. 2018 Aug 16;132(7):755-757. doi: 10.1182/blood-2018-03-838672. Epub 2018 Jun 14. No abstract available.

PMID:
29903887
15.

High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers.

White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V.

Bone Marrow Transplant. 2018 Dec;53(12):1593-1595. doi: 10.1038/s41409-018-0242-1. Epub 2018 Jun 8. No abstract available.

PMID:
29884854
16.

Echocardiography and Survival in Light Chain Cardiac Amyloidosis: Back to Basics.

Siddiqi OK, Sanchorawala V, Ruberg FL.

Circ Cardiovasc Imaging. 2018 May;11(5):e007826. doi: 10.1161/CIRCIMAGING.118.007826. No abstract available.

PMID:
29752394
17.

Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients.

Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K.

Transfus Apher Sci. 2018 Jun;57(3):411-415. doi: 10.1016/j.transci.2018.04.025. Epub 2018 Apr 26.

PMID:
29731423
18.

Once AL amyloidosis: not always AL amyloidosis.

Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V.

Amyloid. 2018 Jun;25(2):139-140. doi: 10.1080/13506129.2018.1449104. Epub 2018 Mar 8. No abstract available.

PMID:
29516761
19.

Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation.

Havasi A, Doros G, Sanchorawala V.

Am J Hematol. 2018 May;93(5):E129-E132. doi: 10.1002/ajh.25066. Epub 2018 Feb 24. No abstract available.

20.

Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).

Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S.

Amyloid. 2018 Mar;25(1):62-67. doi: 10.1080/13506129.2018.1436048. Epub 2018 Feb 9.

Supplemental Content

Loading ...
Support Center